Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cowellmedi
Busan, Gyeongsangnam-do, South Korea
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Cowellmedi is a pioneer in the dental biotechnology sector, known for developing South Korea's first dental implant and the world's first rhBMP-2 based bone graft material for dental applications. Their clinical results demonstrate high success rates in alveolar bone regeneration and osseointegration using their recombinant protein and implant technologies.
- Therapeutic areas
- RheumatologyOther
- Modalities
- Recombinant proteinDeviceBiologic
- Industry
- Biotech
02
Partnerships
Seoul National University Dental HospitalPusan National University Dental Hospital
Beyond the preview
Go deeper on Cowellmedi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cowellmedi.